Forgot your password?
New user?
Nanoparticle fear over anti-odour socks
Fragment-based Lead Discovery Conference 2008
test conference
Document Actions
Twelfth Arden House European Conference
| Type | Conference |
|---|---|
| Language | English |
| Date |
March 12, 2007
to March 14, 2007 |
| Venue |
Royal Pharmaceutical Society HQ 1 Lambeth High Street london, SE1 7JN GB |
| Chemistry Specialties |
|
| Chemistry Techniques |
|
| Contact |
Susan Hughes RPSGB 1 Lambeth High Street london, SE1 7JN GB 020 7572 2640 020 7572 2506 science@rpsgb.org |
| Add event to calendar |
vCal (Windows, Linux)
iCal (Mac OS X)
|
The parenteral route remains an important route of delivery of medicines for the pharmaceutical industry for both small molecules and, increasingly, biologics. This conference will address the current best practices, challenges and trends associated with the development, manufacture and registration of parenteral products
Speakers
Dr Paul Gellert, AstraZeneca, UK
Dr Michael Akers, Baxter, USA
Paul Cummings (GlaxoSmithKline)
Frank Guethlein, Novartis
Simon Holland, GlaxoSmithKline, UK
Paul Newby, Pfizer, UK
Karoline Bechtold-Peters (Boehringer-Ingelheim)
Christine Wurth, Roche
Steve Shire, Genentech
Dr Ralf Ostendorp, Morphosys
Trevor Deeks, Skanska Pharmaceutical Group Ltd
Otto Schubert, Roche
James Drinkwater, Bioquell, UK
Dr Markus Lankers, Rap.ID Particle systems GmbH, Germany
Juergen Sigg, Novartis
Jessica Ballinger, Pfizer
Anders Lofgren, AstraZeneca
Michael Ausborn, Roche
Kostas Kostarelos, University of London, UK
Dr Dieter Roethlisberger, Haffmann-La Roche, Switzerland
Emer Cooke, European Medicines Agency